TYK2 as a novel therapeutic target in Alzheimer Disease
Laura E. König, Steve Rodriguez, Clemens B. Hug, Shayda Daneshvari, Alexander Chung, Gary Andrew Bradshaw, Aslı Şahin, George Zhou, Robyn J. Eisert, Federica Piccioni, Sudeshna Das, Marian Kalocsay, Artem Sokolov, Peter Karl Sorger, David E. Root, Mark W. Albers
The paper identifies TYK2 as a potential therapeutic target for neurodegenerative diseases by linking cdsRNA-induced inflammation to interferon signaling and demonstrating protective effects of TYK2 inhibitors.
bioRxiv · Jun 4, 2024 · PreprintNeuroscience